Octocog alfa
Octocog alfa (ADVATE; BAY 81-8973; Kovaltry) is a standard half-length recombinant coagulation factor FVIII replacement therapy that also functions as a thrombin generation modulator. Octocog alfa regulates thrombin generation-related parameters in vitro and is used in studies related to severe hemophilia A.
For research use only. We do not sell to patients.
- CAS No.: 139076-62-3
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
Chemical Information
-
CAS No. 139076-62-3
-
SMILES
[Octocog alfa]
-
Synonyms
ADVATE; BAY 81-8973; Kovaltry
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Müller J, et al. Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A. Haemophilia. 2024;30(5):1203-1209. [Content Brief]
[2]. Lissitchkov T, et al. Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa. Res Pract Thromb Haemost. 2023;7(4):100176. Published 2023 May 13. [Content Brief]
[3]. Klamroth R, et al. Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A. Haemophilia. 2016;22(5):730-738. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)